Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide with CPT in Fragile R/R PTCL
NCT02879526Phase 2Unknown
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Aug 2016
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tucidinostat in peripheral T-cell lymphoma (PTCL), sponsored by Jiangsu Provincial People's Hospital. Status: unknown.
02
Drugs
tucidinostat
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT02879526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02879526.